Table 1 Characteristics of Study Subjects
From: Characteristics of visit-to-visit blood pressure variability in hemodialysis patients
Variable | Total sample (n = 324) |
|---|---|
Age (years old) | 70 (26–97) |
Gender (male/female) | 183/141 |
Body mass index (kg/m2) | 21.5 (19.2–23.9) |
Performance status (0/1/2/3/4) | 0/143/96/68/17 |
Primary disease (DM/non DM) | 157/167 |
Duration of hemodialysis therapy (months) | 2.0 (0.5–5.0) |
Smoking history (yes/no) | 84/240 |
Past history of cardiovascular diseases (yes/no) | 128/196 |
Antihypertensive treatment (RAS-I/β-blocker/CCB) | 249/96/211 |
Kt/V | 1.36 (1.2–1.56) |
CTR (%) | 51.2 (48.0–56.0) |
Average of %BW (%) | 4.1 (3.0–5.3) |
Blood tests | |
Hemoglobin (g/dl) | 10.8 ± 1.2 |
HDL-cholesterol (mg/dl) | 46.0 (37.0–57.0) |
LDL-cholesterol (mg/dl) | 83.5 ± 28.4 |
Triglyceride (mg/dl) | 97.0 (67.0–134.0) |
Calcium (mg/dl) | 8.8 (8.4–9.2) |
Inorganic phosphorus (mg/dl) | 4.9 (4.1–5.9) |
Intact-Parathyroid hormone (pg/ml) | 114.0 (70.9–168.0) |
Creatinine (mg/dl) | 8.8 ± 2.6 |
Uric acid (mg/dl) | 6.6 (5.9–7.6) |
CRP (mg/dl) | 0.1 (0.1–0.3) |
hANP (pg/ml) | 66.0 (46.8–94.3) |
BNP (pg/ml) | 148.9 (75.1–313.9) |
Albumin (g/dl) | 3.9 (3.6–4.0) |
Glycoalbumin (%) | 19.1 (16.2–22.7) |
Physical function tests | |
Echocardiography | |
LVEF (%) | 67.1 (61.0–75.2) |
LVMI (g/m2) | 169.9 (138.8–206.7) |
E/A | 0.74 (0.61–0.91) |
Dec-T (ms) | 232.3 (189.4–282.0) |
baPWV (cm/s) | |
Higher values | 1970.0 (1677.0–2335.0) |
Average values | 1927.5 (1638.5–2289.5) |
SBP parameters (at beginning/after 6 months) | |
Pre-VIM | 12.5 (9.9–15.3)/11.3 (9.3–14.5) |
Post-VIM | 12.3 (9.4–15.6)/11.3 (8.8–14.1) |
Maximum of Δ (mmHg) | 60 (46–78)/54 (42–70) |
Average of Δ (mmHg) | 33.3 (27.2–44.2)/31.2 (25.7–39.9) |
Percentage of Δ (%) | 20.6 (16.9–26.8)/19.7 (16.6–24.9) |
Minimum of the lowest SBP (mmHg) | 103 ± 12/106 (90-106) |
Average of the lowest SBP (mmHg) | 125 ± 11/123 ± 6 |
